60 computer-programmer-"https:"-"UCL" "https:" "https:" "https:" "https:" "University of St" research jobs
Sort by
Refine Your Search
-
Listed
-
Country
-
Program
-
Employer
-
Field
-
health resources, mindfulness programs and courses, employee assistance program (EAP), financial resources, access to dietitians, and more! Family We offer 4 weeks of caregiver leave to bond with your new
-
% at WashU and 40% elsewhere after seven years with us. For policies, detailed benefits, and eligibility, please visit: https://hr.wustl.edu/benefits/ EEO Statement Empty heading Washington University in St
-
% at WashU and 40% elsewhere after seven years with us. For policies, detailed benefits, and eligibility, please visit: https://hr.wustl.edu/benefits/ EEO Statement Empty heading Washington University in St
-
, annual health screenings, mental health resources, mindfulness programs and courses, employee assistance program (EAP), financial resources, access to dietitians, and more! Family We offer 4 weeks
-
, such as health care. Connections working at Washington University in St. Louis More Jobs from This Employer https://main.hercjobs.org/jobs/21901855/postdoctoral-fellow-school-of-public-health Return
-
We are delighted to welcome applications for a Research Fellow post within the ESRC Connecting Generations programme to examine intergenerational flows of support in later life and the increased
-
, detailed benefits, and eligibility, please visit: https://hr.wustl.edu/benefits/ EEO Statement Empty heading Washington University in St. Louis is committed to the principles and practices of equal
-
) Country United Kingdom Application Deadline 6 Feb 2026 - 00:00 (UTC) Type of Contract Other Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme
-
direct services, such as health care. Connections working at Washington University in St. Louis More Jobs from This Employer https://main.hercjobs.org/jobs/21888461/postdoctoral-research-associate
-
role in immune modulation. In addition, the lab also has a robust program in development of small molecule inhibitors as therapeutic option for these cancers. The lab has previously identified multiple